Unlock instant, AI-driven research and patent intelligence for your innovation.

PNS cell lines and methods of use therefor

a cell line and cell technology, applied in the field of pns cell lines, can solve the problems of limiting the number of cells in such cultures, unable to generally effective treat pns disorders, and affecting the development of pns disorders therapy,

Inactive Publication Date: 2005-05-05
SIGNAL PHARM INC
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0006] Briefly stated, the present invention provides conditionally-immortalized human PNS progenitor cell lines capable of differentiation into neurons. In one aspect, the present invention provides methods for producing a conditionally-immortalized rat neural crest stem cell, comprising: (a) transfecting rat neural crest cells plated on a first surface and in a first growth medium that permit proliferation with DNA encoding a selectable marker and regulatab

Problems solved by technology

For example, there are no generally effective therapies for PNS disorders such as chronic pain, diabetic neuropathy, chemotherapy-induced neuropathy and Charcot-Marie Tooth, a genetic form of peripheral neuropathy.
The development of therapies for PNS disorders has been considerably hampered by the lack of sufficient cells for research and development.
However, the limited number of cells in such cultures represents a substantial drawback for most biochemical and molecular studies, which require more material that such cultures can readily provide.
Such properties have made these cell lines beneficial for research and drug development, but the use of these cell lines has been limited by the low percentage of cells that differentiate and by the loss of the ability to differentiate upon passaging.
Furthermore, some cell lines exhibit both neural and glial characteristics, and human cells are presently unavailable.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • PNS cell lines and methods of use therefor
  • PNS cell lines and methods of use therefor
  • PNS cell lines and methods of use therefor

Examples

Experimental program
Comparison scheme
Effect test

example 1

Retroviral Optimization for Immortalization of PNS Cell Lines

[0085] This Example illustrates the optimization of efficiency of retroviral infection of human PNS progenitor cells.

[0086] HEK293 cells (ATCC Accession No. CRL 1573) cultured in DMEM, 10% fetal bovine serum plus pen-strep (100 units / mL penicillin G plus 100 μg / mL streptomycin sulfate) were transiently co-transfected, using the calcium phosphate system (Promega ProFection kit, Promega, Madison, Wis.), with pMD.G (Naldini et al., Science 272:263-267, 1996; Naldini et al., Proc. Natl. Acad. Sci. USA 93:11382-11388, 1996) (VSV-G expression), pBS.CMV.gag.pol (within a Bluescript KS+ backbone, the immediate early CMV promoter is used to express gag / pol from Moloney Leukemia Virus, followed by a bovine polyA sequence) and pLINX v-myc (tetracycline-regulatable v-myc; see Hoshimaru et al., Proc. Natl. Acad. Sci. USA 93:1518-1523, 1996) simultaneously. After approximately 16 hours, the supernatant from the culture was collected a...

example 2

Human PNS Cell Line Development

[0088] This Example illustrates the conditional immortalization of human DRG neural precursors.

[0089] Human fetal DRG cultures were retrovirally infected with VSV-G pseudotyped LINX v-myc, the tetracycline-regulatable v-myc oncogene. A number of putative clones were isolated by limiting dilution. Specifically, DRGs were dissociated with 1 mg / ml collagenase plus 3.6 mg / ml dispase for 20 to 40 minutes at 37° C., with mechanical trituration every 10 minutes. In one case, DNAse (0.1 mg / ml) was included during the last trituration set. The dissociated cells were plated in t-15C (see below for components), FGF-2 (40 ng / ml) plus pen-strep (50 units / mL penicillin G plus 50 μg / mL streptomycin sulfate) onto fibronectin-coated tissue culture plastic at a density of 1.1-2.5×105 cells per 60 mm dish. Cultures were infected for 19 hours with 50-100 μL of VSV-G pseudotyped LINX v-myc retrovirus in the presence of 4 μg / ml polybrene. The retrovirus was then removed b...

example 3

Rat PNS Cell Line Development

[0108] This Example illustrates the conditional immortalization of rat neural crest stem cells and DRG neural precursor cells.

A. Immortalization of Neural Crest Stem Cells

[0109] Cultures of neural crest stem cells were successfully infected with the tetracycline-regulatable v-myc oncogene. It was necessary to modify the published protocol for culturing neural crest stem cells (Stemple and Anderson, Cell 71:973-985, 1992) in order to successfully infect neural crest stem cell cultures with the immortalizing oncogene. Specifically, in order to successfully infect neural crest stem cells, it was necessary to increase the concentration of FGF-2 from 4 ng / ml to 40 ng / ml, and eliminate retinoic acid, EGF and NGF from the published feeding medium. Embryonic day 10.5 rat neural tubes were dissected, dissociated partially with collagenase, and then plated into L-15C plus FGF-2 onto a fibronectin substrate. Cultures were infected for about 24 hours with amphot...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Conditionally-immortalized PNS progenitor cell lines are provided. Such cell lines, which may be clonal, may be used to generate neurons. The cell lines and / or differentiated cells may be used for the development of therapeutic agents to prevent and treat a variety of PNS-related diseases. The cell lines and / or differentiated cells may also be used in assays and for the general study of PNS cell development, death and abnormalities.

Description

TECHNICAL FIELD [0001] The present invention relates generally to PNS cell lines. The invention is more particularly related to conditionally-immortalized neural crest stem cell lines and dorsal root ganglion progenitor cell lines, and to differentiated cells derived from such cell lines. Such cell lines and / or differentiated cells may be used in the development of therapeutic agents for the prevention and treatment of neurological diseases and other conditions. The present invention is also related to the use of such cell lines and / or differentiated cells n assays and for the study of PNS cell development, death and abnormalities. BACKGROUND OF THE INVENTION [0002] The peripheral nervous system (PNS), which comprises the autonomic nervous system and the sensory nervous system, can be affected by a variety of disorders that are currently difficult to treat. For example, there are no generally effective therapies for PNS disorders such as chronic pain, diabetic neuropathy, chemothera...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N33/50A61K35/30A61P25/00A61P25/04C07K14/82C12N5/02C12N5/0797C12N5/10C12N15/09C12Q1/68
CPCC07K14/82C12N2740/13043G01N33/5058C12N2503/00C12N2510/04C12N5/0623A61P25/00A61P25/04
Inventor SAH, DINAH W. Y.RAYMON, HEATHER K.
Owner SIGNAL PHARM INC